| [1] |
Becattini C, Manina G. Long-term treatment of venous thromboembolism[J]. Curr Vasc Pharmacol, 2014, 12(3): 384-392.
|
| [2] |
Galambosi PJ, Ulander VM, Kaaja RJ. The incidence and risk factors of recurrent venous thromboembolism during pregnancy[J]. Thromb Res, 2014, 134(2):240-245
|
| [3] |
Bucciarelli P, De Stefano V, Passamonti SM, et al. Influence of proband′s characteristics on the risk for venous thromboembolism in relatives with factor V Leiden or prothrombin G20210A polymorphisms[J]. Blood, 2013, 122(15): 2555-2561.
|
| [4] |
Tam WH, Ng MH, Yiu AK, et al. Thrombophilia among Chinese women with venous thromboembolism during pregnancy[J]. Gynecol Obstet Invest, 2012, 73(3): 183-188.
|
| [5] |
Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) [J]. J Thromb Haemost, 2006, 4(2): 295-306.
|
| [6] |
De Vries JI, Kist WJ, Hague WM. Confounded thrombophilia studies in preeclampsia[J]. Am J Obstet Gynecol, 2009, 201(5): e11-e12.
|
| [7] |
Mello G, Parretti E, Marozio L, et al. Thrombophilia is significantly associated with severe preeclampsia: results of a large-scale, case-controlled study[J]. Hypertension, 2005, 46(6):1270-1274.
|
| [8] |
Hafner E, Metzenbauer M, Hofinger D, et al. Comparison between three-dimensional placental volume at 12 weeks and uterine artery impedance/notching at 22 weeks in screening for pregnancy-induced hypertension, pre-eclampsia and fetal growth restriction in a low-risk population[J]. Ultrasound Obstet Gynecol, 2006, 27(6): 652-657.
|
| [9] |
Bates SM, Greer IA, Middeldorp S, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J]. Chest, 2012, 141(2 Suppl): e691S-e736S.
|
| [10] |
Toyoda K. Antithrombotic therapy for pregnant women[J]. Neurol Med Chir (Tokyo). 2013, 53(8):526-530.
|
| [11] |
Kutteh WH, Hinote CD. Antiphospholipid antibody syndrome[J]. Obstet Gynecol Clin North Am, 2014, 41(1):113-132.
|
| [12] |
Warkentin TE, Greinacher A, Koster A, et al. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)[J]. Chest, 2008, 133(6 Suppl): 340S-380S.
|